Skip to main content
. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086

Fig 1. Tumor size.

Fig 1

A) Tumor cross-sectional area at different time points post injection of 2x104 AT1-, or 1x103 MLL tumor cells into the ventral prostate (bars represent mean +/- SD, n = 7–8 animals/group, * p < 0.05). B) Representative eosin-hematoxylin stained sections showing intraprostatic AT1- and MLL-tumors at day 3 and 14 after tumor cell injection (T; tumor).